课题基金 / 基金详情

PREDICTORS OF VINCA ALKALOID PHARMACOKINETICS

PREDICTORS OF VINCA ALKALOID PHARMACOKINETICS
长春花生物碱药代动力学的预测因子
批准号:
2682497
负责人:
SHARON Anne LOBERT
金额:
$11.2万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-09-01 至 2002-08-31

项目摘要

项目成果

SHARON Anne LOBERT的其他基金

相似基金

相关文献

中文摘要
翻译
描述:(申请人摘要)这项拟议的研究将增加 我们对抗肿瘤疗效的生化基础的认识和 长春花碱的剂量限制性毒性。最终目标是 为化疗药物的设计提供了理论基础, 更有效,毒性更低。长春花碱已经成为长春花碱的支柱 在过去的三十年里,有许多化疗方案;然而,只有 目前在美国和欧洲有四种长春花碱。这个 药物受体是微管纺锤体纤维的主要成分微管蛋白 在细胞分裂中必不可少的。Vincas破坏微管动力学必不可少 用于有丝分裂,并诱导形成非微管螺旋聚合物。 化学结构非常相似的药物,如长春新碱和 长春花碱,具有非常不同的毒性特征和独特的,以及 相互重叠的抗肿瘤药效。造成这些药物差异的原因 都躲过了研究人员,而在没有这些知识的情况下,理性药物设计 被阻碍了。对药物受体能量学的认识 相互作用是解释药代动力学和 药效学数据。到目前为止,还不可能获得可靠的 长春花碱结合亲和力的估算(药物诱导的微管蛋白 螺旋势),用于结构-功能比较。改进 近年来的技术使分析超速离心法成为一种有用的方法。 用于容易地收集所需的多个数据集的方法 定量结合研究。申请人已经完成了热力学课程 8种长春花碱的沉降速度分析。就是她 假设细胞药物摄取与微管蛋白的大小一起 螺旋的形成与药物在细胞内的滞留和细胞毒性有关。 申请人建议确定化学修饰如何增强 或抑制螺旋形成在体外和体内影响长春花碱的作用 细胞。这项研究的具体目的是系统地分析 八种长春花碱的化学修饰对细胞的影响 增殖,2)细胞对药物的摄取和保留,3)体外 微管组装;4)单个微管动力学。这些数据 将与之前确定的总体药物结合情况进行比较 亲和力(诱导微管蛋白螺旋的可能性)。这项工作将衍生出 预测药物药代动力学的体外标准,并将有助于 了解药物的细胞毒性作用。
英文摘要
DESCRIPTION: (Applicant's Abstract) This proposed research will increase our understanding of the biochemical basis for the antitumor efficacy and the dose-limiting toxicities of vinca alkaloids. The ultimate goal is to provide a rationale for the design of chemotherapeutic agents that are both more effective and less toxic. Vinca alkaloids have become the mainstay of numerous chemotherapy protocols over the past thirty years; however, only four vinca alkaloids are currently available in the U.S. and Europe. The drug receptor is tubulin, the major component of microtubule spindle fibers essential in cell division. Vincas disrupt microtubule dynamics essential for mitosis and induce the formation of nonmicrotubule spiral polymers. Drugs with very similar chemical structures, such as vincristine and vinblastine, have very different toxicity profiles and unique, as well as overlapping antitumor efficacies. The reasons for these drug differences have eluded researchers and without this knowledge rational drug design has been hampered. An understanding of the energetics of drug-receptor interactions is essential for interpreting pharmacokinetic and pharmacodynamic data. Until now it has not been possible to obtain reliable estimates of vinca alkaloid binding affinities (drug-induced tubulin spiraling potential) for structure-function comparisons. Improved technology in recent years has made analytical ultracentrifugation a useful method for readily collecting the multiple data sets necessary for quantitative binding studies. The applicant has completed a thermodynamic analysis of eight vinca alkaloids using sedimentation velocity. It is her hypothesis that cellular drug uptake together with the magnitude of tubulin spiral formation correlate with drug retention by cells and cytotoxicity. The applicant proposes to identify how chemical modifications that enhance or inhibit spiral formation influence vinca alkaloid effects in vitro and in cells. The specific aims of this research are to systemically assay the effect of chemical modifications of eight vinca alkaloids on 1) cell proliferation, 2) drug uptake and retention by cells, 3) in vitro microtubule assembly and 4) individual microtubule dynamics. These data will be compared with the previously determined overall drug binding affinities (potential for inducing tubulin spirals). This work will derive in vitro criteria to predict drug pharmacokinetics and will contribute to understanding drug cytotoxic effects.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.bpc.2006.05.023
发表时间: 2007-03
期刊: Biophysical chemistry
影响因子: 3.8
作者: [S. Lobert;J. W. Ingram;J. Correia]
通讯作者: S. Lobert;J. W. Ingram;J. Correia
Additivity of dilantin and vinblastine inhibitory effects on microtubule assembly.
Dilantin 和长春花碱对微管组装的抑制作用的加和性。
DOI: --
发表时间: 1999
期刊: Cancer research.
影响因子: --
作者: [Lobert,S, Ingram,JW, Correia,JJ]
通讯作者: Correia,JJ
DOI: 10.1186/bcr631
发表时间: 2003
期刊: Breast cancer research : BCR
影响因子: --
作者: [Dozier JH, Hiser L, Davis JA, Thomas NS, Tucci MA, Benghuzzi HA, Frankfurter A, Correia JJ, Lobert S]
通讯作者: Lobert S
INTERACTIONS OF ANTIMITOTICS WITH TUBULIN ISOTYPES
  • 批准号:
    2256587
  • 项目类别:
  • 资助金额:
    $7.48万
  • 财政年份:
    1993
  • 负责人:
    SHARON Anne LOBERT
  • 依托单位:
INTERACTIONS OF ANTIMITOTICS WITH TUBULIN ISOTYPES
  • 批准号:
    2256585
  • 项目类别:
  • 资助金额:
    $7.54万
  • 财政年份:
    1993
  • 负责人:
    SHARON Anne LOBERT
  • 依托单位:
INTERACTIONS OF ANTIMITOTICS WITH TUBULIN ISOTYPES
  • 批准号:
    2256586
  • 项目类别:
  • 资助金额:
    $7.48万
  • 财政年份:
    1993
  • 负责人:
    SHARON Anne LOBERT
  • 依托单位:
INTERACTIONS OF ANTIMITOTICS WITH TUBULIN ISOTYPES
  • 批准号:
    2416211
  • 项目类别:
  • 资助金额:
    $7.56万
  • 财政年份:
    1993
  • 负责人:
    SHARON Anne LOBERT
  • 依托单位:
海外基金